Company description

Sanofi Active Ingredient Solutions cover both APIs sales and Contract Development and Manufacturing. We provide expertise in Quality, Regulatory and Supply and have dedicated commercial teams for our customers around the globe.

Quick facts

Sales markets North America
Affiliated categories: Analytical Chemistry |Antibiotics |Antibodies More

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 2248 See our Exhibitor Profile   See full Exhibitor List

News about Sanofi

Sanofi to create standalone European API production powerhouse

24 Feb 2020

Sanofi to create standalone European API production powerhouse

Sanofi's plans to create a European company to manufacture and market active pharmaceutical ingredients (APIs) should help to balance the region's heavy reliance on sourcing them from Asian markets, the French pharmaceutical firm said Monday.

Read more

6 Dec 2019

Sanofi bolsters its immuno-oncology pipeline for $2.5B

Lead asset THOR-707 being explored across multiple solid tumor types alone and in combination with immune checkpoint inhibitors and other future IO combinations.

Read more

10 Feb 2019

FDA approves first Nanobody-based medicine for adults with aTTP

Cablivi is the first US approval for Sanofi's new rare blood disorders franchise.

Read more

Contact information




View all contact information